Costamare Inc 8.50% Series C Preferred Stock
CMRE.PRC
2 hedge funds and large institutions have $4.54M invested in Costamare Inc 8.50% Series C Preferred Stock in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
4% more capital invested
Capital invested by funds: $4.38M → $4.54M (+$162K)
0.29% more ownership
Funds ownership: 4.94% → 5.24% (+0.29%)
0% more funds holding
Funds holding: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LKIM
Lawson Kroeker Investment Management
Omaha,
Nebraska
|
+$340K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KIA
KCM Investment Advisors
Greenbrae,
California
|
-$102K |
CMRE.PRC Hedge Fund Activity: Q4 2016 in Review
2 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Costamare Inc 8.50% Series C Preferred Stock (CMRE.PRC) for Q4 2016, worth a combined $4.54M — up 3.7% from $4.38M a quarter earlier.
Fund positioning in CMRE.PRC was balanced in Q4 2016: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Lawson Kroeker Investment Management, adding an estimated $340K. The largest seller was KCM Investment Advisors, cutting an estimated $102K.
- 2 institutional investors held Costamare Inc 8.50% Series C Preferred Stock (CMRE.PRC) as of Q4 2016, unchanged from Q3 2016.
- Funds reported $4.54M of Costamare Inc 8.50% Series C Preferred Stock stock for Q4 2016, up 3.7% quarter-over-quarter.
- 0 funds opened new Costamare Inc 8.50% Series C Preferred Stock positions in Q4 2016 and 0 closed out.
- The largest Costamare Inc 8.50% Series C Preferred Stock buyer in Q4 2016 was Lawson Kroeker Investment Management, an estimated $340K added.
- The largest Costamare Inc 8.50% Series C Preferred Stock seller in Q4 2016 was KCM Investment Advisors, an estimated $102K sold.
Based on aggregated 13F filings for Q4 2016.